The Critical Role of Quality Systems in Secondary Packaging
In pharmaceutical secondary packaging, quality is not merely an inspection checkpoint—it is the foundational pillar of patient safety and brand protection. Regulatory health authorities, including the US FDA, EMA, and local drug regulatory bodies, enforce strict Current Good Manufacturing Practices (cGMP) that require secondary packaging converters to maintain the same standards of cleanliness, segregation, and documentation as drug formulation facilities.
1. Formal 3-Tier Line Clearance Protocols
The primary risk during high-speed printing and converting is the potential for product mix-ups. At Prince Art Packages, every production cell adheres to a documented 3-tier line clearance Standard Operating Procedure (SOP):
- Pre-Run Clearance: Complete physical evacuation of all plates, dies, carton waste, and documentation from the previous run.
- Dual Verification: Independent inspection and signature sign-off by both the Line Incharge and the Quality Assurance Inspector.
- Post-Run Reconciliation: Verification that total sheet inputs equal finished cartons plus documented process waste.
2. Spectrophotometric Delta-E Color Control
Brand integrity and anti-counterfeiting rely heavily on color consistency. Utilizing closed-loop inline spectrophotometers calibrated to X-Rite Pantone digital libraries, we maintain Delta-E color variances under 1.5 across millions of printed cartons.
3. Complete Batch Manufacturing Records (BMR)
Every delivered shipment is accompanied by a formal Certificate of Analysis (CoA) and Batch Manufacturing Record detailing machine operators, substrate lot numbers, ink batch certificates, and optical scan logs.
